HK1092219A1 - Method for detecting neoplastic disorders in a solubilized body sample - Google Patents

Method for detecting neoplastic disorders in a solubilized body sample

Info

Publication number
HK1092219A1
HK1092219A1 HK06113997.0A HK06113997A HK1092219A1 HK 1092219 A1 HK1092219 A1 HK 1092219A1 HK 06113997 A HK06113997 A HK 06113997A HK 1092219 A1 HK1092219 A1 HK 1092219A1
Authority
HK
Hong Kong
Prior art keywords
cervical
body sample
solubilized
carcinomas
sample
Prior art date
Application number
HK06113997.0A
Other languages
English (en)
Inventor
Ruediger Ridder
Anja Reichert
Knebel Doeberitz Magnus Von
Matthias Herkert
Alexander Duwe
Rainer Hipfel
Peter Martin
Original Assignee
Mtm Lab Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mtm Lab Ag filed Critical Mtm Lab Ag
Publication of HK1092219A1 publication Critical patent/HK1092219A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Peptides Or Proteins (AREA)
HK06113997.0A 2003-08-25 2006-12-20 Method for detecting neoplastic disorders in a solubilized body sample HK1092219A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03103218A EP1507148B1 (en) 2003-08-25 2003-08-25 Method for detecting carcinomas in a solubilized cervical body sample
PCT/EP2004/051872 WO2005088311A1 (en) 2003-08-25 2004-08-20 Method for detecting neoplastic disorders in a solubilized body sample

Publications (1)

Publication Number Publication Date
HK1092219A1 true HK1092219A1 (en) 2007-02-02

Family

ID=33560881

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06113997.0A HK1092219A1 (en) 2003-08-25 2006-12-20 Method for detecting neoplastic disorders in a solubilized body sample

Country Status (14)

Country Link
US (1) US7932047B2 (ja)
EP (2) EP1507148B1 (ja)
JP (2) JP5619336B2 (ja)
CN (1) CN1836166B (ja)
AT (2) ATE289685T1 (ja)
AU (1) AU2004317284B2 (ja)
BR (1) BRPI0414030B8 (ja)
CA (1) CA2528490C (ja)
DE (2) DE60300339T2 (ja)
ES (1) ES2342535T3 (ja)
HK (1) HK1092219A1 (ja)
MX (1) MXPA05013903A (ja)
RU (1) RU2405158C2 (ja)
WO (2) WO2005088311A1 (ja)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601497B2 (en) 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
EP1510820B1 (en) * 2003-08-25 2010-03-17 MTM Laboratories AG Method for detecting medically relevant conditions in a solubilized LBC sample
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
CN101460636A (zh) 2006-05-11 2009-06-17 伯克顿迪金森公司 从细胞中提取蛋白质的方法
US8968995B2 (en) 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
WO2010129821A1 (en) * 2009-05-07 2010-11-11 Oncohealth Corporation Identification of high grade or ≥cin2 for early stages and late stages detection, screening, and diagnosis of human papillomavirus (hpv) and hpv-associated cancers
US8278056B2 (en) * 2008-06-13 2012-10-02 Oncohealth Corp. Detection of early stages and late stages HPV infection
US9207240B2 (en) 2007-11-14 2015-12-08 Arbor Vita Corporation Method of efficient extraction of protein from cells
US10365279B2 (en) 2008-01-25 2019-07-30 Berg Llc Assay system for the assessment of oncogenicity, tumor progression, and treatment efficacy
US20090204009A1 (en) * 2008-02-07 2009-08-13 Los Alamos National Security Medical device system and related methods for diagnosing abnormal medical conditions based on in-vivo optical properties of tissue
US8728745B2 (en) 2008-09-04 2014-05-20 Ventana Medical Sysems, Inc. Method for prediction of the progression risk of tumors
US8288520B2 (en) * 2008-10-27 2012-10-16 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and system
CN101487845B (zh) * 2009-02-19 2013-01-02 苏州海路生物技术有限公司 大便标本自动检测仪
AU2010242867B2 (en) 2009-05-01 2016-05-12 Qiagen Gaithersburg, Inc. A non-target amplification method for detection of RNA splice-forms in a sample
EP2521914A4 (en) * 2010-01-08 2013-07-10 Oncohealth Corp CELL-BASED HPV IMMUNOTESTS HAVE A HIGH PERFORMANCE FOR DIAGNOSIS AND SCANNING OF HPV ASSOCIATED CANCER
CA2787924A1 (en) 2010-01-29 2011-08-04 Qiagen Gaithersburg, Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
US9605303B2 (en) 2010-01-29 2017-03-28 Qiagen Gaithersburg, Inc. Method of determining and confirming the presence of an HPV in a sample
EP2572001A2 (en) 2010-05-19 2013-03-27 QIAGEN Gaithersburg, Inc. Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
WO2011149897A1 (en) 2010-05-25 2011-12-01 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes
JP5841941B2 (ja) * 2010-06-17 2016-01-13 国立大学法人 岡山大学 ｍｉｃｒｏＲＮＡ標的遺伝子検出用キット及びｍｉｃｒｏＲＮＡ標的遺伝子の検出方法
GB201014335D0 (en) * 2010-08-27 2010-10-13 Forensic Science Service Ltd Improvements in and relating to analysis
NZ608814A (en) 2010-09-03 2015-06-26 Stem Centrx Inc Novel modulators and methods of use
CN102033056B (zh) * 2010-10-14 2012-05-30 中国科学院化学研究所 抑制膜蛋白受体聚集的抗癌药物鉴定方法
CA2828224A1 (en) 2011-02-24 2012-08-30 Qiagen Gaithersburg, Inc. Materials and methods for detection of hpv nucleic acids
US20140329230A1 (en) 2011-11-15 2014-11-06 University Of Miami Methods for detecting human papillomavirus and providing prognosis for head and neck squamous cell carcinoma
RU2508542C1 (ru) * 2012-07-16 2014-02-27 Полина Михайловна Шварцбурд Экспресс-способ определения риска злокачественности клеток
RU2535071C1 (ru) * 2013-04-09 2014-12-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановская государственная медицинская академия" Министерства здравоохранения Российской Федерации Способ диагностики недифференцированной дисплазии соединительной ткани у женщин с потерей беременности в анамнезе
CN111537718A (zh) * 2013-07-31 2020-08-14 迈阿密大学 用于鉴别受试者的癌症风险的组合物和方法
WO2015147370A1 (en) * 2014-03-28 2015-10-01 Seegene, Inc. Detection of target nucleic acid sequences using different detection temperatures
RU2558987C1 (ru) * 2014-04-21 2015-08-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ диагностики степени тяжести недифференцированной дисплазии соединительной ткани у женщин репродуктивного возраста
ES2911415T3 (es) 2015-06-08 2022-05-19 Arquer Diagnostics Ltd Métodos y kits
US11519916B2 (en) 2015-06-08 2022-12-06 Arquer Diagnostics Limited Methods for analysing a urine sample
CN106610434A (zh) * 2016-02-26 2017-05-03 弗雷米德生物医药技术（天津）有限公司 一种hpv16型e7蛋白的elisa检测试剂盒
RU2680930C2 (ru) * 2017-03-24 2019-02-28 федеральное государственное бюджетное образовательное учреждение высшего образования "Северный государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ забора материала для цитологического исследования при опухолевых заболеваниях поджелудочной железы, печени и желчевыводящих путей
CN107748265A (zh) * 2017-09-29 2018-03-02 中南大学湘雅医院 Cdc6和ki67在制备癌症放疗抵抗的诊断标记物中的应用
US20210196751A1 (en) * 2017-12-29 2021-07-01 Vertex Pharmaceuticals Incorporated Methods of cancer treatment using an atr inhibitor
US11230729B2 (en) 2018-04-20 2022-01-25 Inanna Diagnostics, Inc Methods and devices for obtaining cellular and DNA material from human female reproductive system
CN109781977B (zh) * 2019-01-09 2022-03-29 首都医科大学附属北京安定医院 IL15Rα以及相关膜蛋白检测试剂盒及其应用
RU2707099C1 (ru) * 2019-04-24 2019-11-22 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации Способ скрининга злокачественных опухолей органов грудной полости
MX2019005940A (es) * 2019-05-21 2019-10-11 Atso Corp Affairs S A De C V Biomarcadores relacionados a cancer.

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5889169A (en) 1991-05-16 1999-03-30 Cold Spring Harbor Laboratory Cell cycle regulatory protein p16 gene
CA2103161A1 (en) 1991-05-16 1992-11-17 David H. Beach D-type cyclin and uses related thereto
EP0643836B1 (en) * 1991-12-13 1999-09-08 Bion Diagnostic Sciences, Inc. Agglutination assays and kits employing colloidal dyes
US6316208B1 (en) 1994-01-07 2001-11-13 Memorial Sloan-Kettering Cancer Center Methods for determining isolated p27 protein levels and uses thereof
AU685627B2 (en) 1994-03-18 1998-01-22 Myriad Genetics, Inc. Germline mutations in the MTS gene and method for detecting predisposition to cancer at the MTS gene
US6060301A (en) 1994-03-18 2000-05-09 Myriad Genetics, Inc. Vector containing MTS1E1β gene
US5989815A (en) 1994-03-18 1999-11-23 University Of Utah Research Foundation Methods for detecting predisposition to cancer at the MTS gene
CA2164167A1 (en) 1994-12-20 1996-06-21 Izak Bahar Assay normalization method
US6033847A (en) 1995-02-06 2000-03-07 St. Jude Children's Research Hospital InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
US5843756A (en) 1995-06-07 1998-12-01 Myriad Genetics, Inc. Mouse MTSI gene
US6403383B1 (en) 1996-03-11 2002-06-11 American Bio Medica Corp. Diagnostic test kit for immunological assays of fluid samples
US5976799A (en) 1996-03-21 1999-11-02 The Board Of Trustees Of The University Of Arkansas Early detection of ovarian carcinoma using P16 gene products
US5858683A (en) 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer
WO1999004238A2 (en) 1997-07-15 1999-01-28 Mitotix, Inc. Reagents and methods for diagnosis and prognosis of proliferative disorders
US6090579A (en) 1997-08-12 2000-07-18 Smithkline Beecham Corporation Human SDR2 cDNA clone
EP1038029A2 (en) 1997-12-12 2000-09-27 Digene Corporation Universal collection medium
US20010051364A1 (en) 1997-12-23 2001-12-13 Francis Michon Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
US5994079A (en) 1998-02-06 1999-11-30 Digene Corporation Direct detection of RNA mediated by reverse transcriptase lacking RNAse H function
US7399589B2 (en) 1998-02-06 2008-07-15 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US6686151B1 (en) 1998-02-06 2004-02-03 Digene Corporation Immunological detection of RNA:DNA hybrids on microarrays
US6576420B1 (en) * 1998-06-23 2003-06-10 Regents Of The University Of California Method for early diagnosis of, and determination of prognosis in, cancer
EP1388734B1 (en) 2002-08-01 2004-03-03 MTM Laboratories AG Method for solution based diagnosis
US7306926B2 (en) 1998-07-01 2007-12-11 Mtm Laboratories Ag Method for detecting carcinomas in a solubilized cervical body sample
DE19829473C2 (de) 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
WO2000031538A1 (en) * 1998-11-23 2000-06-02 Praxsys Biosystems, Inc. Improved lateral flow assays
SE515668C2 (sv) * 1999-02-22 2001-09-17 Quantovir Ab Metod och kit för tidig förutsägelse av cancer
DE10014685B4 (de) 2000-03-24 2004-07-01 Schubert, Walter, Dr. Verfahren zur Identifizierung von zellspezifischen Zielstrukturen
GB0018140D0 (en) 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
DE10063179A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
ITRM20010363A1 (it) * 2001-06-25 2001-09-24 Franco Castelmani Gancio adattivo applicato ad un generatore di vivrazioni sinusoidali.
ES2654909T3 (es) * 2002-01-07 2018-02-15 Pretect As Método para detectar ARNm del virus del papiloma humano
EP1333278B1 (en) 2002-02-01 2004-03-10 MTM molecular tools in medicine Methods for monitoring and prognosis of disease course of gastrointestinal tumors
US7361460B2 (en) * 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases

Also Published As

Publication number Publication date
BRPI0414030B8 (pt) 2021-07-27
JP5619336B2 (ja) 2014-11-05
ATE461449T1 (de) 2010-04-15
DE60300339D1 (de) 2005-03-31
WO2005088311A1 (en) 2005-09-22
US7932047B2 (en) 2011-04-26
DE60300339T2 (de) 2006-04-13
CA2528490A1 (en) 2005-09-22
US20070190529A1 (en) 2007-08-16
AU2004317284B2 (en) 2009-11-05
JP5677270B2 (ja) 2015-02-25
JP2007503208A (ja) 2007-02-22
EP1507148A1 (en) 2005-02-16
WO2005084103A2 (en) 2005-09-15
CA2528490C (en) 2015-11-03
JP2012032412A (ja) 2012-02-16
ES2342535T3 (es) 2010-07-08
BRPI0414030B1 (pt) 2017-04-04
MXPA05013903A (es) 2006-03-09
RU2405158C2 (ru) 2010-11-27
RU2006101395A (ru) 2006-06-10
CN1836166A (zh) 2006-09-20
DE602004026014D1 (de) 2010-04-29
AU2004317284A1 (en) 2005-09-22
BRPI0414030A (pt) 2007-01-23
ATE289685T1 (de) 2005-03-15
EP1507148B1 (en) 2005-02-23
CN1836166B (zh) 2010-05-26
EP1664788A1 (en) 2006-06-07

Similar Documents

Publication Publication Date Title
HK1092219A1 (en) Method for detecting neoplastic disorders in a solubilized body sample
NO20006681D0 (no) Fremgangsmåte ved tidlig diagnose av karsinomer
AU2003230254A1 (en) Method of diagnosis of foot and mouth disease and the diagnostic kit
MX2007005053A (es) Metodo para evaluar la enfermedad de alzheimer y reactivo de diagnostico.
AU2003213594A1 (en) Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
EP2503338A3 (en) CD73 as a biomarker for monitoring development of diseases and assessing the efficacy of therapies
EP1708745A4 (en) ANTIBODIES FOR ONCOGEN STRAINS OF HPV AND METHODS OF USE
WO2001055719A3 (en) Diagnostic kit for detecting creatine levels
BR0314155A (pt) Métodos para diagnosticar câncer cervical
WO2006067792A3 (en) Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease
PL1977244T3 (pl) Rozróżnianie bakteryjnego i wirusowego zapalenia opon mózgowych
SG140505A1 (en) Diagnostic biomolecule(s)
WO2004113574A3 (en) Methods for disease screening
AU2002233800A1 (en) Method and kit for predicting cancer
WO2004071273A3 (en) Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
WO2004045364A3 (en) Methods of detecting ovarian neoplasia
WO2006112962A3 (en) Syphilis diagnostic test and kits
WO2004093662A3 (en) Method for detecting prognosis of cancer
EP1988164A4 (en) METHOD FOR TESTING THE SENSITIVITY OF SOLIC CANCER AGAINST A TYROSINE KINASE INHIBITOR AND CORRESPONDING TEST REQUIREMENTS
AU2490102A (en) Method for diagnosing a tumor in a patient determining the concentration of pibf
AU2003299389A8 (en) PRP detection method using an aminoglycoside antibiotic
GB0225885D0 (en) Quantifying exposure to stress
ATE441859T1 (de) Verfahren zur diagnose der immunität wiederkehrenden spontanen schwangerschaftsabbruchs sowie verfahren zur behandlung und überwachung

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20240816